News from correvio pharma corp A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 21, 2020, 16:01 ET Correvio Obtains Final Order for Plan of Arrangement

NASDAQ: CORV TSX: CORV VANCOUVER, May 21, 2020 /CNW/ - Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing...


May 15, 2020, 17:55 ET Correvio Announces Results from Annual General and Special Meeting of Securityholders

Securityholders Approve ADVANZ PHARMA Acquisition NASDAQ: CORV TSX: CORV VANCOUVER, May 15, 2020 /CNW/ - Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), today...


May 06, 2020, 08:00 ET Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVANZ PHARMA

NASDAQ: CORV TSX: CORV VANCOUVER, May 6, 2020 /CNW/ - Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), today announced that Glass, Lewis & Co., LLC ("Glass Lewis"), a...


May 04, 2020, 08:00 ET Correvio Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19

NASDAQ: CORV TSX: CORV VANCOUVER, May 4, 2020 /CNW/ - Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing...


May 01, 2020, 08:00 ET Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA

NASDAQ: CORV TSX: CORV VANCOUVER, May 1, 2020 /CNW/ - Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), today announced that Institutional Shareholder Services Inc....


Apr 08, 2020, 16:05 ET Correvio Obtains Interim Order For Plan Of Arrangement

NASDAQ: CORV TSX: CORV VANCOUVER, April 8, 2020 /CNW/ - Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing...


Mar 30, 2020, 07:00 ET Correvio Reports Full Year 2019 Financial Results

ADVANZ PHARMA to Acquire Correvio in a Deal Valued at US$76 Million Correvio to Hold a Meeting of Its Securityholders by No Later than May 20, 2020 Transaction Expected to Close During the Second...


Mar 16, 2020, 07:00 ET ADVANZ PHARMA to Acquire Correvio

NASDAQ: CORV TSX: CORV Acquisition Expected to Have a Total Purchase Price of Approximately US$76 Million Including the Repayment of Certain Correvio Indebtedness ADVANZ PHARMA Intends to Pay for the ...


Mar 10, 2020, 07:30 ET Correvio Partners with Hong Kong Teson Pharma Limited for the Commercialization of Aggrastat® in China

NASDAQ: CORV TSX: CORV VANCOUVER and HONG KONG, March 10, 2020 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs,...


Mar 02, 2020, 08:30 ET Correvio Responds to Market Activity

NASDAQ: CORV TSX: CORV VANCOUVER, March 2, 2020 /CNW/ - At the request of Investment Industry Regulatory Organization of Canada ("IIROC"), Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV) (the...


Jan 28, 2020, 08:00 ET Correvio Receives NASDAQ Notification Regarding Deficiencies In Minimum Bid Price And Market Value Of Listed Securities

NASDAQ: CORV TSX: CORV VANCOUVER, Jan. 28, 2020 /CNW/ - Correvio Pharma Corp. (Nasdaq: CORV) (TSX: CORV), ("Correvio" or the "Company") announced today that it has received two written notifications...


Dec 24, 2019, 08:00 ET Correvio Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events

NASDAQ: CORV TSX: CORV VANCOUVER, Dec. 24, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced ...


Dec 11, 2019, 08:00 ET Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value

NASDAQ: CORV TSX: CORV VANCOUVER, Dec. 11, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced ...


Dec 10, 2019, 16:38 ET Correvio Announces Outcome Of FDA Advisory Committee Meeting Reviewing Brinavess™ For The Treatment Of Recent Onset Atrial Fibrillation

NASDAQ: CORV TSX: CORV VANCOUVER, Dec. 10, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced ...


Dec 10, 2019, 07:05 ET Correvio Stock Trading Halted Today; FDA Advisory Committee Meeting To Discuss Brinavess™ For Recent Onset Atrial Fibrillation

NASDAQ: CORV TSX: CORV VANCOUVER, Dec. 10, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced ...


Nov 25, 2019, 08:00 ET Correvio to Present at the Piper Jaffray 31st Annual Healthcare Conference

NASDAQ: CORV TSX: CORV VANCOUVER, Nov. 25, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced ...


Nov 18, 2019, 08:00 ET Correvio Announces Presentation of New Brinavess™ Spectrum Data at the American Heart Association 2019 Annual Meeting

NASDAQ: CORV TSX: CORV Post Hoc Analysis of Subset of Patients Treated in the Emergency Department Setting Safety Outcomes of Interest Observed in Less Than 1% Cases; No Deaths Reported Greater Than...


Nov 14, 2019, 07:00 ET Correvio Reports Third Quarter 2019 Financial Results

NASDAQ: CORV TSX: CORV FDA Accepts Brinavess™ New Drug Application Advisory Committee Date Set for December 10, 2019 PDUFA Date Set for December 24, 2019 Management to Host Conference Call and...


Nov 07, 2019, 08:00 ET Correvio to Report Third Quarter 2019 Financial Results

NASDAQ: CORV TSX: CORV Conference Call Scheduled for Thursday, November 14, 2019 at 8:30 a.m. Eastern (5:30 a.m. Pacific) VANCOUVER, Nov. 7, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX:...


Nov 04, 2019, 07:00 ET Correvio Announces FDA Advisory Committee Meeting to Review Brinavess™ for Recent Onset Atrial Fibrillation

NASDAQ: CORV TSX: CORV VANCOUVER, Nov. 4, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced...


Sep 27, 2019, 07:00 ET Correvio to Present at the 2019 Cantor Global Healthcare Conference

NASDAQ: CORV TSX: CORV VANCOUVER, Sept. 27, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today...


Sep 12, 2019, 07:00 ET Correvio Highlights FDA Acceptance of United Therapeutics' Trevyent New Drug Application

NASDAQ: CORV TSX: CORV VANCOUVER, Sept. 12, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today...


Sep 04, 2019, 08:00 ET Correvio to Present at the H.C. Wainwright 21st Annual Global Investment Conference

NASDAQ: CORV TSX: CORV VANCOUVER, Sept. 4, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced ...


Sep 03, 2019, 08:00 ET Correvio Announces Presentation Of Brinavess® Spectrum Data At The European Society Of Cardiology 2019 Congress

Safety Outcomes of Interest Observed in Less Than 1% Cases; Zero Deaths Reported Greater Than 70% of Atrial Fibrillation Episodes Successfully Converted to Sinus Rhythm in a Median Time of 12 Minutes ...


Aug 14, 2019, 07:00 ET Correvio Reports Second Quarter 2019 Financial Results

FDA Accepts New Drug Application for BrinavessTM; PDUFA Date Set for December 24, 2019 Recently Strengthened Balance Sheet Extends Cash Runway Into Mid-2020 Management to Host Conference Call and...